About this trial
Virtual Reality (VR) is gaining traction as a new and innovative leisure to augment healthcare services. Several benefits of the leisure experience, such as distraction and full sensory immersion, have demonstrated a potential to significantly impact the field of healthcare through pain reduction, anxiety reduction, and is seen as an innovative approach to motor learning. Persons with ALS (pwALS) have a high prevalence of anxiety over the course of their illness, which has a negative impact on their quality of life, and the quality of life of those closest to them. The use of VR for anxiety management and subsequent quality of life improvement has yet to be explored in the ALS population.
For individuals with ALS, VR can be both (1) an escape from the reality of living day to day with a progressive fatal diagnosis; and (2) the opportunity to potentially improve anxiety, both of which are linked to the quality of life of individuals living with ALS. Our hypothesis is that a simple and accessible home VR-guided relaxation exercise program can improve subjective anxiety symptoms in a person living with ALS and subsequently improve quality of life.
Eligibility criteria
Qualifiers
Diagnosed with ALS (gold coast or El-Escorial), or ALS variants of flail limb, progressive muscle atrophy, UMN or LMN predominant
Able to use VR device with no negative effects (i.e. headaches, vision changes, dizziness, nausea, disorientation)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Virtual Reality Guided Breathing Exercise
Treatment groups
Locations
Sponsors and collaborators
Horizon Health Network
Lead sponsor
University of Saskatchewan
Collaborator
Nova Scotia Health Authority
Collaborator
Hamilton Health Sciences Corporation
Collaborator
Queen's University, Kingston, Ontario
Collaborator